Delivery Order SPE2DB22D3004-SPE2DB25FSG68
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Jardiance 25 mg tablets (30-count packaging) under a firm fixed-price contract valued at $2,260.38. This non-set-aside competitive award is classified as a delivery order, with an ultimate completion date of July 29, 2025. The pharmaceutical distributor will perform this work at its corporate headquarters location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $6,657.98. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for completion by September 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units) valued at $3,784.87. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $51,243.85. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $2,858.49. This firm fixed-price delivery order is set to be completed by August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, competitively awarded contract under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $10,745.91. This firm fixed-price delivery order is set to be completed by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Jardiance 25 mg tablets in a 90-count package, with a contract ceiling value of $76,202.50. This firm fixed-price delivery order is set to complete by September 11, 2025, and will be fulfilled from the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a pharmaceutical procurement supporting the federal government's medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $6,717.68. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The order is scheduled for ultimate completion on August 15, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a contract value of $5,425.98 and a completion date of September 3, 2025. This delivery order represents a firm fixed-price, non-set-aside award made through open competition, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The place of performance is located...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,446.65 delivery order on August 4, 2025, for the supply of Jardiance 25 mg tablets (90-count). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSG68Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $1,861.15. This firm fixed-price delivery order, which is due for completion by September 4, 2025, represents a continuation of AmerisourceBergen's role as a pharmaceutical supplier to the federal government. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill the order from its corporate office location. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. That prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, including diabetes treatments, to support military healthcare programs worldwide. AmerisourceBergen has demonstrated consistent capability in fulfilling federal medical procurement requirements through open competition, servicing customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/3/25 |